carbon monoxide has been researched along with Pneumonia, Pneumococcal in 4 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
Pneumonia, Pneumococcal: A febrile disease caused by STREPTOCOCCUS PNEUMONIAE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mycoplasma pneumoniae is a frequent but underdiagnosed cause of community-acquired pneumonia (CAP) in children, and appropriate macrolide treatment is often given late." | 2.69 | Reduced lung diffusion capacity after Mycoplasma pneumoniae pneumonia. ( Chaussain, M; Gendrel, D; Iniguez, JL; Kalifa, G; Marc, E; Moulin, F; Raymond, J, 2000) |
| "Inhaled carbon monoxide (CO) gas has therapeutic potential for patients with acute respiratory distress syndrome if a safe, evidence-based dosing strategy and a ventilator-compatible CO delivery system can be developed." | 1.42 | Effects of inhaled CO administration on acute lung injury in baboons with pneumococcal pneumonia. ( Baron, RM; Choi, AM; Davies, JD; Fredenburgh, LE; Harris, RS; Hess, DR; Kraft, BD; Piantadosi, CA; Roggli, VL; Stenzler, A; Suliman, HB; Thompson, BT; Welty-Wolf, KE; Winkler, T; Wolf, MA, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shinohara, M | 2 |
| Kibi, M | 1 |
| Riley, IR | 1 |
| Chiang, N | 2 |
| Dalli, J | 2 |
| Kraft, BD | 3 |
| Piantadosi, CA | 3 |
| Choi, AM | 3 |
| Serhan, CN | 2 |
| Colas, RA | 1 |
| Fredenburgh, LE | 2 |
| Hess, DR | 2 |
| Welty-Wolf, K | 1 |
| Harris, RS | 1 |
| Wolf, MA | 1 |
| Suliman, HB | 1 |
| Roggli, VL | 1 |
| Davies, JD | 1 |
| Winkler, T | 1 |
| Stenzler, A | 1 |
| Baron, RM | 1 |
| Thompson, BT | 1 |
| Welty-Wolf, KE | 1 |
| Marc, E | 1 |
| Chaussain, M | 1 |
| Moulin, F | 1 |
| Iniguez, JL | 1 |
| Kalifa, G | 1 |
| Raymond, J | 1 |
| Gendrel, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase Ib Trial of Inhaled Carbon Monoxide for the Treatment of Pneumonia and Sepsis-Induced Acute Respiratory Distress Syndrome (ARDS)[NCT04870125] | Phase 1 | 36 participants (Anticipated) | Interventional | 2023-12-06 | Recruiting | ||
| A Phase II Trial of Inhaled Carbon Monoxide for the Treatment of Acute Respiratory Distress Syndrome (ARDS)[NCT03799874] | Phase 2 | 32 participants (Anticipated) | Interventional | 2019-07-01 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for carbon monoxide and Pneumonia, Pneumococcal
| Article | Year |
|---|---|
Cell-cell interactions and bronchoconstrictor eicosanoid reduction with inhaled carbon monoxide and resolvin D1.
Topics: Acute Lung Injury; Animals; Antimetabolites; Carbon Monoxide; Cell Communication; Docosahexaenoic Ac | 2014 |
Reduced lung diffusion capacity after Mycoplasma pneumoniae pneumonia.
Topics: Adolescent; Anti-Bacterial Agents; Carbon Monoxide; Child; Child, Preschool; Female; Follow-Up Studi | 2000 |
2 other studies available for carbon monoxide and Pneumonia, Pneumococcal
| Article | Year |
|---|---|
The Regulation of Proresolving Lipid Mediator Profiles in Baboon Pneumonia by Inhaled Carbon Monoxide.
Topics: Administration, Inhalation; Animals; Carbon Monoxide; Drug Evaluation, Preclinical; Immunologic Fact | 2015 |
Effects of inhaled CO administration on acute lung injury in baboons with pneumococcal pneumonia.
Topics: Acute Lung Injury; Administration, Inhalation; Animals; Anti-Bacterial Agents; Antioxidants; Carbon | 2015 |
Effects of inhaled CO administration on acute lung injury in baboons with pneumococcal pneumonia.
Topics: Acute Lung Injury; Administration, Inhalation; Animals; Anti-Bacterial Agents; Antioxidants; Carbon | 2015 |
Effects of inhaled CO administration on acute lung injury in baboons with pneumococcal pneumonia.
Topics: Acute Lung Injury; Administration, Inhalation; Animals; Anti-Bacterial Agents; Antioxidants; Carbon | 2015 |
Effects of inhaled CO administration on acute lung injury in baboons with pneumococcal pneumonia.
Topics: Acute Lung Injury; Administration, Inhalation; Animals; Anti-Bacterial Agents; Antioxidants; Carbon | 2015 |